Edward Chong

885 total citations
24 papers, 417 citations indexed

About

Edward Chong is a scholar working on Geriatrics and Gerontology, Transplantation and Physiology. According to data from OpenAlex, Edward Chong has authored 24 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Geriatrics and Gerontology, 8 papers in Transplantation and 8 papers in Physiology. Recurrent topics in Edward Chong's work include Frailty in Older Adults (11 papers), Renal Transplantation Outcomes and Treatments (8 papers) and Nutrition and Health in Aging (8 papers). Edward Chong is often cited by papers focused on Frailty in Older Adults (11 papers), Renal Transplantation Outcomes and Treatments (8 papers) and Nutrition and Health in Aging (8 papers). Edward Chong collaborates with scholars based in Singapore, Austria and Germany. Edward Chong's co-authors include Mark Y. Chan, Laura Tay, Wee Shiong Lim, Yew Yoong Ding, Georg A. Böhmig, Arjang Djamali, Peter Nickerson, Konstantin Doberer, Farsad Eskandary and Justin Chew and has published in prestigious journals such as Transplantation, Age and Ageing and Diabetic Medicine.

In The Last Decade

Edward Chong

22 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Chong Singapore 9 237 161 124 103 85 24 417
Sunitha Suresh United States 11 104 0.4× 53 0.3× 69 0.6× 40 0.4× 6 0.1× 31 484
Vickie Wai-Ki Kwong Hong Kong 13 65 0.3× 70 0.4× 70 0.6× 78 0.8× 16 0.2× 19 381
Osamu Soma Japan 12 71 0.3× 55 0.3× 24 0.2× 89 0.9× 9 0.1× 27 330
Yvonne C. Schrama Netherlands 9 34 0.1× 22 0.1× 38 0.3× 175 1.7× 67 0.8× 21 536
Jeanette M. Hasse United States 12 26 0.1× 336 2.1× 7 0.1× 268 2.6× 52 0.6× 46 678
Claire Sokas United States 10 70 0.3× 93 0.6× 23 0.2× 115 1.1× 13 0.2× 26 340
Noori Chowdhury Canada 9 39 0.2× 62 0.4× 8 0.1× 268 2.6× 99 1.2× 15 381
Ana Vigil Spain 11 14 0.1× 44 0.3× 26 0.2× 85 0.8× 7 0.1× 18 391
Golara Zahmatkesh United States 7 11 0.0× 68 0.4× 14 0.1× 89 0.9× 48 0.6× 8 319
J. M. López‐Gómez Spain 8 6 0.0× 58 0.4× 31 0.3× 76 0.7× 126 1.5× 14 462

Countries citing papers authored by Edward Chong

Since Specialization
Citations

This map shows the geographic impact of Edward Chong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Chong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Chong more than expected).

Fields of papers citing papers by Edward Chong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Chong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Chong. The network helps show where Edward Chong may publish in the future.

Co-authorship network of co-authors of Edward Chong

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Chong. A scholar is included among the top collaborators of Edward Chong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Chong. Edward Chong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chong, Edward, et al.. (2025). Exploring the anti-obesity effects of Lactobacillus in C57BL/6 mice: mechanisms, interventions, and future directions. Letters in Applied Microbiology. 78(3). 2 indexed citations
2.
Chong, Edward, et al.. (2024). Functional Dependency as a Marker for Positive SARC-F Screen among Older Persons at the Emergency Department. Annals of Geriatric Medicine and Research. 28(4). 401–409.
3.
Chong, Edward, et al.. (2022). Evaluating Quality-of-Life, Length of Stay and Cost-Effectiveness of a Front-Door Geriatrics Program: An Exploratory Proof-of-Concept Study. The Journal of Frailty & Aging. 12(3). 214–220. 3 indexed citations
4.
Lion, Julien, Jean‐Luc Taupin, Karine Poussin, et al.. (2022). Restriction of interleukin‐6 alters endothelial cell immunogenicity in an allogenic environment. Clinical Transplantation. 37(3). e14851–e14851. 3 indexed citations
5.
Nickerson, Peter, Georg A. Böhmig, Steve Chadban, et al.. (2022). Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design. Trials. 23(1). 1042–1042. 22 indexed citations
6.
Lion, Julien, Jean‐Luc Taupin, Karine Poussin, et al.. (2022). Restriction of interleukin‐6 alters endothelial cell immunogenicity in an allogenic environment. Clinical Transplantation. 36(12). e14815–e14815. 1 indexed citations
7.
Eskandary, Farsad, Susanne Haindl, Konstantin Doberer, et al.. (2022). Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Renal Allograft Rejection: Accumulation of Antibody-neutralized Interleukin-6 Without Signs of Proinflammatory Rebound Phenomena. Transplantation. 107(2). 495–503. 8 indexed citations
8.
Mühlbacher, Jakob, Christian Schörgenhofer, Konstantin Doberer, et al.. (2021). Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism. Transplant International. 34(8). 1542–1552. 7 indexed citations
9.
Chong, Edward, et al.. (2021). Emergency Department Interventions for Frailty (EDIFY): Front-Door Geriatric Care Can Reduce Acute Admissions. Journal of the American Medical Directors Association. 22(4). 923–928.e5. 24 indexed citations
10.
Chong, Edward, et al.. (2021). SARC-F at the Emergency Department: Diagnostic Performance for Frailty and Predictive Performance for Reattendances and Acute Hospitalizations. The journal of nutrition health & aging. 25(9). 1084–1089. 5 indexed citations
11.
Chong, Edward, et al.. (2021). Concurrent and Predictive Validity of FRAIL-NH in Hospitalized Older Persons: An Exploratory Study. Journal of the American Medical Directors Association. 22(8). 1664–1669.e4. 4 indexed citations
12.
13.
14.
Irish, William, Peter Nickerson, Brad C. Astor, et al.. (2020). Change in Estimated GFR and Risk of Allograft Failure in Patients Diagnosed With Late Active Antibody-mediated Rejection Following Kidney Transplantation. Transplantation. 105(3). 648–659. 26 indexed citations
15.
Eskandary, Farsad, Michael Dürr, Klemens Budde, et al.. (2019). Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial. Trials. 20(1). 37–37. 41 indexed citations
16.
Chong, Edward, et al.. (2019). Validating a Standardised Approach in Administration of the Clinical Frailty Scale in Hospitalised Older Adults. Annals of the Academy of Medicine Singapore. 48(4). 115–124. 22 indexed citations
17.
Chong, Edward, Mark Y. Chan, Wee Shiong Lim, & Yew Yoong Ding. (2018). Frailty Predicts Incident Urinary Incontinence Among Hospitalized Older Adults—A 1-Year Prospective Cohort Study. Journal of the American Medical Directors Association. 19(5). 422–427. 33 indexed citations
18.
Chong, Edward, et al.. (2017). Frailty and Risk of Adverse Outcomes in Hospitalized Older Adults: A Comparison of Different Frailty Measures. Journal of the American Medical Directors Association. 18(7). 638.e7–638.e11. 98 indexed citations
19.
Chong, Edward, et al.. (2017). Frailty in Hospitalized Older Adults: Comparing Different Frailty Measures in Predicting Short- and Long-term Patient Outcomes. Journal of the American Medical Directors Association. 19(5). 450–457.e3. 83 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sunitha Suresh Breakdown of academic impact, for papers by Vickie Wai-Ki Kwong Breakdown of academic impact, for papers by Osamu Soma Breakdown of academic impact, for papers by Yvonne C. Schrama Breakdown of academic impact, for papers by Jeanette M. Hasse Breakdown of academic impact, for papers by Claire Sokas Breakdown of academic impact, for papers by Noori Chowdhury Breakdown of academic impact, for papers by Ana Vigil Breakdown of academic impact, for papers by Golara Zahmatkesh Breakdown of academic impact, for papers by J. M. López‐Gómez
Rankless by CCL
2026